Coherus BioSciences Inc (CHRS)
2.18
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 09:37
Coherus BioSciences Profit Margin (Quarterly): -87.03% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -87.03% |
| September 30, 2023 | -53.16% |
| June 30, 2023 | -73.01% |
| March 31, 2023 | -233.5% |
| December 31, 2022 | -129.8% |
| September 30, 2022 | -190.8% |
| June 30, 2022 | -83.37% |
| March 31, 2022 | -159.8% |
| December 31, 2021 | -62.32% |
| September 30, 2021 | -46.70% |
| June 30, 2021 | -34.12% |
| March 31, 2021 | -208.3% |
| December 31, 2020 | 8.79% |
| September 30, 2020 | 24.60% |
| June 30, 2020 | 43.51% |
| March 31, 2020 | 30.62% |
| December 31, 2019 | 31.67% |
| September 30, 2019 | 42.12% |
| June 30, 2019 | 28.25% |
| March 31, 2019 | -53.92% |
| December 31, 2018 |
| Date | Value |
|---|---|
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | -3.97K% |
| March 31, 2017 | -46.45K% |
| December 31, 2016 | -9.00K% |
| September 30, 2016 | 51.55% |
| June 30, 2016 | -497.3% |
| March 31, 2016 | -529.1% |
| December 31, 2015 | -513.7% |
| September 30, 2015 | -995.3% |
| June 30, 2015 | -856.5% |
| March 31, 2015 | -700.9% |
| December 31, 2014 | -448.7% |
| September 30, 2014 | -49.04% |
| June 30, 2014 | -502.7% |
| March 31, 2014 | -699.9% |
| December 31, 2013 | -1.18K% |
| September 30, 2013 | -4.24K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-233.5%
Minimum
Mar 2023
43.51%
Maximum
Jun 2020
-60.65%
Average
-53.16%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| AbbVie Inc | 5.75% |
| Inovio Pharmaceuticals Inc | -24.36K% |
| Nektar Therapeutics | -176.2% |
| Avid Bioservices Inc | -37.44% |
| Stereotaxis Inc | -110.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -46.35% |
| Return on Invested Capital | -77.98% |
| Gross Profit Margin (Quarterly) | 7.60% |
| Operating Margin (Quarterly) | -75.29% |
| Return on Net Operating Assets | -86.78% |